| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |